It will also allow us to decipher the subclonal composition of less well studied subgroups of CLL, such as subsets expressing stereotyped BcR IGs, associated with distinct outcomes (Figure 1) (17). The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.